tiprankstipranks
Vivoryon Therapeutics AG (NL:VVY)
:VVY
Netherlands Market
VVY
Vivoryon Therapeutics AG
RESEARCH TOOLSreports
Want to see NL:VVY full AI Analyst Report?

Vivoryon Therapeutics AG (VVY) Income Statement

1 Followers

Vivoryon Therapeutics AG Income Statement

Last quarter (Q4 2025), Vivoryon Therapeutics AG's total revenue was €0.00, a decrease of -100.00% from the same quarter last year. In Q4, Vivoryon Therapeutics AG's net income was €-3.38M. See Vivoryon Therapeutics AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 0.00€ 0.00€ -3.62M€ 0.00€ 10.76M
Gross Profit
€ -147.00K€ -147.00K€ -3.10M€ -161.00K€ 9.03M
Operating Expenses
€ 9.03M€ 20.81M€ 25.74M€ 28.97M€ 21.84M
Depreciation and Amortization
€ 147.00K€ 147.00K€ 167.00K€ 161.00K€ 165.00K
EBITDA
€ -9.03M€ -20.34M€ -28.35M€ -28.17M€ -12.03M
Operating Income
€ -9.18M€ -20.96M€ -28.84M€ -29.13M€ -12.81M
Other Income/Expenses
€ 324.00K€ 393.00K€ 261.00K€ 777.00K€ 575.00K
Pretax Income
€ -8.85M€ -20.57M€ -28.58M€ -28.36M€ -12.22M
Net Income
€ -8.85M€ -20.57M€ -28.34M€ -28.16M€ -12.65M
Per Share Metrics
Basic EPS
€ -0.33€ -0.79€ -1.12€ -1.28€ -0.63
Diluted EPS
€ -0.33€ -0.79€ -1.12€ -1.28€ -0.63
Weighted Average Shares Outstanding
 26.99M 26.04M 25.24M 22.02M 20.00M
Weighted Average Shares Outstanding (Diluted)
 26.99M 26.04M 25.24M 22.02M 20.00M
Currency in EUR

Vivoryon Therapeutics AG Earnings and Revenue History